Boubekeur N - Search Results

1

HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation.

Tardy C, Goffinet M, Boubekeur N, Cholez G, Ackermann R, Sy G, Keyserling C, Lalwani N, Paolini JF, Dasseux JL, Barbaras R, Baron R. Tardy C, et al. Among authors: boubekeur n. PLoS One. 2015 Sep 3;10(9):e0137584. doi: 10.1371/journal.pone.0137584. eCollection 2015. PLoS One. 2015. PMID: 26335690 Free PMC article.

2

CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.

Tardy C, Goffinet M, Boubekeur N, Ackermann R, Sy G, Bluteau A, Cholez G, Keyserling C, Lalwani N, Paolini JF, Dasseux JL, Barbaras R, Baron R. Tardy C, et al. Among authors: boubekeur n. Atherosclerosis. 2014 Jan;232(1):110-8. doi: 10.1016/j.atherosclerosis.2013.10.018. Epub 2013 Nov 8. Atherosclerosis. 2014. PMID: 24401224

3

P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo.

Goffinet M, Tardy C, Boubekeur N, Cholez G, Bluteau A, Oniciu DC, Lalwani ND, Dasseux JL, Barbaras R, Baron R. Goffinet M, et al. Among authors: boubekeur n. PLoS One. 2014 Apr 25;9(4):e95807. doi: 10.1371/journal.pone.0095807. eCollection 2014. PLoS One. 2014. PMID: 24769858 Free PMC article.

4

Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.

Payré B, de Medina P, Boubekeur N, Mhamdi L, Bertrand-Michel J, Tercé F, Fourquaux I, Goudounèche D, Record M, Poirot M, Silvente-Poirot S. Payré B, et al. Among authors: boubekeur n. Mol Cancer Ther. 2008 Dec;7(12):3707-18. doi: 10.1158/1535-7163.MCT-08-0507. Mol Cancer Ther. 2008. PMID: 19074846

5

Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism.

de Medina P, Payré B, Boubekeur N, Bertrand-Michel J, Tercé F, Silvente-Poirot S, Poirot M. de Medina P, et al. Among authors: boubekeur n. Cell Death Differ. 2009 Oct;16(10):1372-84. doi: 10.1038/cdd.2009.62. Epub 2009 Jun 12. Cell Death Differ. 2009. PMID: 19521424

6

The prototypical inhibitor of cholesterol esterification, Sah 58-035 [3-[decyldimethylsilyl]-n-[2-(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of estrogen receptors.

de Medina P, Boubekeur N, Balaguer P, Favre G, Silvente-Poirot S, Poirot M. de Medina P, et al. Among authors: boubekeur n. J Pharmacol Exp Ther. 2006 Oct;319(1):139-49. doi: 10.1124/jpet.106.104349. Epub 2006 Jul 11. J Pharmacol Exp Ther. 2006. PMID: 16835370

7

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.

Guibert N, Delaunay M, Lusque A, Boubekeur N, Rouquette I, Clermont E, Mourlanette J, Gouin S, Dormoy I, Favre G, Mazieres J, Pradines A. Guibert N, et al. Among authors: boubekeur n. Lung Cancer. 2018 Jun;120:108-112. doi: 10.1016/j.lungcan.2018.04.001. Epub 2018 Apr 3. Lung Cancer. 2018. PMID: 29748004

8

RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition.

Bousquet E, Calvayrac O, Mazières J, Lajoie-Mazenc I, Boubekeur N, Favre G, Pradines A. Bousquet E, et al. Among authors: boubekeur n. Oncogene. 2016 Apr 7;35(14):1760-9. doi: 10.1038/onc.2015.240. Epub 2015 Jul 6. Oncogene. 2016. PMID: 26148238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters